Explore how very high-risk localized prostate cancer is defined and treated, plus why PSMA PET findings shouldn’t automatically rule out curative therapy.
Tamim Niazi, MDCM
Advertisement
Articles by Tamim Niazi, MDCM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026
2
LITESPARK-012: Lessons from a negative phase 3 trial in first-line RCC
3
Novel RIPTAC molecule shows promising activity in heavily pretreated mCRPC
4
ESMO 2026 recap: Notable updates across genitourinary oncology
5